The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The FDA has approved Zepbound, a weight-loss medication, as the first drug treatment for moderate to severe obstructive sleep ...

Sleep apnea, a widespread health issue, causes breathing interruptions during sleep, leading to oxygen deprivation and ...

Sleep apnea, or specifically obstructive sleep apnea (OSA), is linked to hypertension (high blood pressure). OSA affects 30% ...

U.S. regulators have approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...

Sleep apnea is a condition in which breathing stops intermittently while a person sleeps. Read more at straitstimes.com.

The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...

Even before the FDA approval, some doctors have been prescribing weight-loss drugs to people with sleep apnea.

People with breathing problems during sleep may have a larger hippocampus, the area of the brain responsible for memory and ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...